Promotes CRC progression,increases expression of downstream oncogenic target genes, FAK, IGF1R, EGFR, and YY1 that activate PI3K/AKT and MEK/ERK signaling pathways to promote cancer progression and drug resistance. The gene discussed is YY1; the disease is colorectal carcinoma.